ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,433.76
0.63%
Dow Jones
39,512.84
0.32%
Gold vs US Dollar
2,360.48
0.00%
Brent Oil
82.585
0.00%
Bitcoin
61,169.72
0.62%
Pepperstone
Advertisement
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Myogen (MYOG)

  7. Myogen (MYOG) News

Myogen (MYOG)

Myogen
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:MYOG
DateTimeSourceHeadlineSymbolCompany
17/11/200621:02Business WireGilead Sciences Completes Acquisition of MyogenNASDAQ:MYOGMyogen
06/11/200613:00Business WireDarusentan Data to Be Presented at AHA 2006 -- ChicagoNASDAQ:MYOGMyogen
17/10/200621:00Business WireDarusentan Data to Be Presented at ISH 2006 -- Fukuoka, JapanNASDAQ:MYOGMyogen
10/10/200613:00Business WireFour Ambrisentan Studies to Be Presented at Chest 2006 -- Salt Lake CityNASDAQ:MYOGMyogen
02/10/200617:11PR Newswire (US)Seven Summits Research Releases Comments on GOOG, ABX, HET, CBS, and MYOGNASDAQ:MYOGMyogen
02/10/200612:00Business WireGilead Sciences to Acquire Myogen, Inc. for $2.5 BillionNASDAQ:MYOGMyogen
20/09/200613:30Business WireMyogen to Present at the UBS Global Life Sciences ConferenceNASDAQ:MYOGMyogen
07/09/200613:00Business WireMyogen Initiates Open-Label Phase 3 Clinical Trial of Ambrisentan in Patients with Pulmonary HypertensionNASDAQ:MYOGMyogen
06/09/200613:00Business WireThe American Lung Association and Myogen Announce Pulmonary Arterial Hypertension Educational PartnershipNASDAQ:MYOGMyogen
07/08/200621:00Business WireMyogen Reports 2006 Second Quarter ResultsNASDAQ:MYOGMyogen
25/07/200612:45Business WireMyogen to Announce 2006 Second Quarter Results on August 7, 2006NASDAQ:MYOGMyogen
11/07/200613:30Business WireMyogen Announces Extension of Drug Discovery CollaborationNASDAQ:MYOGMyogen
08/06/200612:30Business WireMyogen to Present at the Goldman Sachs Global Healthcare ConferenceNASDAQ:MYOGMyogen
05/06/200613:01Business WireMyogen Initiates Phase 3 Clinical Trial of Darusentan in Patients with Resistant HypertensionNASDAQ:MYOGMyogen
24/05/200611:30Business WireAmbrisentan Phase 3 ARIES-2 PAH Data Presented At ATS 2006 -- San Diego; Significant Improvement in Six-Minute Walk Distance anNASDAQ:MYOGMyogen
08/05/200612:00Business WireMyogen Reports 2006 First Quarter ResultsNASDAQ:MYOGMyogen
03/05/200621:00Business WireMyogen Reports Results for the Integrated Analysis of ARIES-1 and ARIES-2 Pivotal Trials of Ambrisentan in Pulmonary Arterial HNASDAQ:MYOGMyogen
21/04/200612:00Business WireMyogen to Announce 2006 First Quarter Results on May 8, 2006NASDAQ:MYOGMyogen
19/04/200621:00Business WireMyogen to Present at the Leerink Swann Vascular Modlulation ConferenceNASDAQ:MYOGMyogen
10/04/200617:36PR Newswire (US)Seven Summits Research releases comments on AAPL, EBAY, HAL, MYOG, and URBNNASDAQ:MYOGMyogen
10/04/200612:00Business WireMyogen Reports Positive Top Line Results for Second Ambrisentan Pivotal Phase 3 Trial in Pulmonary Arterial Hypertension; ARIESNASDAQ:MYOGMyogen
09/03/200615:57PR Newswire (US)Seven Summits Research Releases Comments on MRVL, DELL, SGP, GENZ, and MYOGNASDAQ:MYOGMyogen
09/03/200613:00Business WireAmbrisentan Receives FDA Fast Track Designation for PAH DevelopmentNASDAQ:MYOGMyogen
06/03/200621:10Business WireMyogen Reports 2005 ResultsNASDAQ:MYOGMyogen
02/03/200613:00Business WireAmbrisentan ARIES-2 Data to Be Presented at ATS 2006 -- San DiegoNASDAQ:MYOGMyogen
28/02/200621:00Business WireMyogen to Present at the Citigroup Small & Mid-Cap ConferenceNASDAQ:MYOGMyogen
13/02/200613:30PR Newswire (US)Myogen Reports Positive Top Line Results for Ambrisentan LFT Rescue Study In Pulmonary Arterial HypertensionNASDAQ:MYOGMyogen
06/02/200615:12PR Newswire (US)NASDAQ Hosts First-Ever Investor Conference in London for Small Cap CompaniesNASDAQ:MYOG
06/02/200613:00PR Newswire (US)Myogen to Announce 2005 Results on March 6, 2006NASDAQ:MYOGMyogen
02/02/200621:30PR Newswire (US)Myogen Announces Sale of Myogen GmbHNASDAQ:MYOGMyogen
 Showing the most relevant articles for your search:NASDAQ:MYOG

Your Recent History

LSE
PET
Petrel Resources
LSE
TERN
Tern
LSE
VAST
Vast Resources
LSE
SCE
Surface Transforms
LSE
GKP
Gulf Keystone Petroleum
LSE
POS
Plexus
LSE
SCLP
Scancell
LSE
OXB
Oxford Biomedica
LSE
EEE
Empire Metals
LSE
ITV
Itv
LSE
AGL
Angle
LSE
PANR
Pantheon Resources
LSE
SRSP
Sirius Petroleum
LSE
GOLD
LSE
ENET
Ethernity Networks
LSE
SYME
Supply@me Capital
Delayed Upgrade Clock
    ADVFN Logo

    United Kingdom
    Company
    Business
    Popular
    Get The App

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved